- Location
NSAID
"-
Naproxen Is Safer for The Heart Than Other Popular Anti-inflammatory Drugs
Feb 25, 2014TUESDAY Feb. 10, 2014, 2014 -- The science isn't convincing enough to say that naproxen -- the key pain reliever in Aleve -- is safer for the heart than other popular anti-inflammatory drugs such as ibuprofen (Advil and Motrin), U.S. health ...
-
NSAIDs Before Vaccinating Horses to Reduce Risk and Severity of Such Reactions
Jan 23, 2014Although vaccination against infectious disease is a routine component of horse care, many owners still voice concerns about their horse's risk of having an adverse reaction to these injections. For this reason, veterinarians sometimes ...
-
The U.S. Food and Drug Administration (FDA) Has Approved The New Drug Application
Jan 17, 2014Mallinckrodt (NYSE: MNK) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for PENNSAID® (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal ...
-
U.S. Food and Drug Administration (FDA) Has Accepted for Review The SNDA
Jan 16, 2014Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
Tags: Iroko Pharmaceuticals, FDA, ZORVOLEX, osteoarthritis pain
-
FDA Has Accepted for Review The Supplemental New Drug Application
Jan 15, 2014Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
-
An Injury or Sleeping The Wrong Way Can Lead to a Major Pain in The Neck
Dec 27, 2013An injury or sleeping the wrong way can lead to a major pain in the neck. The American College of Rheumatology suggests these ways to ease neck pain: Stay as mobile as possible, and limit the use of a neck brace. Avoid regular ...
Tags: health tip, pain in the neck, ease neck pain
-
Iroko Has Entered Into a $75m Debt Facility Agreement with an Affiliate of OrbiMed
Nov 22, 2013US-based Iroko Pharmaceuticals has entered into a $75m debt facility agreement with an affiliate of OrbiMed Advisors (OrbiMed) to support general business operations and the launch of Zorvolex (diclofenac). Zorvolex is the first and only ...
-
LPI Has Launched Its Generic Rabeprazole Sodium Delayed-release Tablets,20mg
Nov 14, 2013Lupin Pharmaceuticals (LPI), a US subsidiary of India-based Lupin, has launched its generic Rabeprazole Sodium delayed-release tablets, 20mg. Earlier, the company had received final approval from the US Food and Drug Administration (FDA) ...
Tags: Lupin Pharma, tablets
-
Iroko Pharmaceuticals Has Received The FDA Approval to Market ZORVOLEX Capsules
Oct 23, 2013US-based iCeutica announced that its partner Iroko Pharmaceuticals has received the US Food and Drug Administration (FDA) approval to market ZORVOLEX (diclofenac) capsules, a non-steroidal anti-inflammatory drug (NSAID) that utilizes ...
-
Imprimis Pharmaceuticals Has Received Approval From The Institutional Review Board
Jul 26, 2013Imprimis Pharmaceuticals has received approval from the Institutional Review Board (IRB) to initiate Phase III clinical trial protocol of its new topical non-steroidal anti-inflammatory drug (NSAID) candidate, Impracor. Impracor is based ...
-
The US FDA Has Issued a CRL to Nuvo Research's US Licensing Partner, Mallinckrodt
Mar 8, 2013The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Nuvo Research's US licensing partner, Mallinckrodt, following the review of Mallinckrodt's New Drug Application (NDA) for diclofenac sodium topical ...
-
FDA Has Accepted to Review Iroko Pharmaceuticals New Drug Application
Mar 8, 2013The US Food and Drug Administration (FDA) has accepted to review Iroko Pharmaceuticals New Drug Application (NDA) for lower dose submicron diclofenac, a non-steroidal anti-inflammatory drug (NSAID), with a proposed indication of treatment ...
Tags: FDA, Pharmaceuticals, Medicine
-
Imprimis Pharmaceuticals Has Announced The Completion of Clinical Trials of Impracor
Feb 21, 2013Imprimis Pharmaceuticals has announced the completion of clinical trials of Impracor, a topical analgesic cream, which delivers a therapeutic dose of the pain-relieving, anti-inflammatory drug ketoprofen. The study, which was conducted by ...
-
InSite Launches a New Durasite 2 Drug Delivery System, Designed to Ophthalmic Therapeutics
Dec 14, 2012InSite Vision has launched a new DuraSite 2 drug delivery system, designed to deliver ophthalmic therapeutics. DuraSite 2, which is based on InSite DuraSite technology, incorporates cataract surgery drug, ketorolac, a non-steroidal ...
Tags: InSite, Ophthalmic Drug Delivery System, ophthalmic therapeutics
-
SAFC Has Inked an Agreement with CrystalGenomics to Develop APIs
Dec 5, 2012Specialty chemicals and biologics supplier SAFC has inked an agreement with CrystalGenomics to develop active pharmaceutical ingredients (APIs) for non-steroidal anti-inflammatory drugs (NSAID). The agreement reflects SAFC's ...
Related Products
-
GMP Certified Best Quality Piroxicam 10mg/20mg Tablet
-
Anti-Inflammation Agent Piroxicam Capsule 10mg/20mg with Good Quality
-
Nsaid Antiinflammatory Material 5104-49-4 Powder Flurbiprofen
-
Nsaid Naproxen 99% CAS 22204-53-1powder
-
Nsaid Meloxicam Capsule 15mg GMP Pharm
-
Anti-Inflammatory Drug (NSAID) Meloxicam Capsule
